| |
| |
|
| Insider
Information: |
Conway Robert |
| Relationship: |
Chairman of the Board,... |
| City: |
Boulder |
| State: |
CO |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
95,000 |
|
|
Indirect Shares
|
50,000 |
|
|
| Direct
Value |
$2,925,465 |
|
|
|
Indirect Value
|
$3,232,000 |
|
|
| Total
Shares |
145,000 |
|
|
| Total
Value |
$6,157,465 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
1
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
1
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
 1.2%
|
 -19.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alpine Immune Sciences Inc |
ALPN |
Director |
2017-05-09 |
45,000 |
2021-09-23 |
50,000 |
Premium* |
|
|
Nuvelo Inc |
ABIO |
Chairman of the Board,... |
2021-05-12 |
50,000 |
2017-03-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALPN |
Alpine Immune Sciences In... |
Director |
– • – |
2021-09-23 |
4 |
S |
$10.08 |
$151,154 |
I/I |
(15,000) |
50,000 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Director |
– • – |
2021-09-23 |
4/A |
B |
$10.08 |
$151,154 |
I/I |
15,000 |
50,000 |
2.1 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Director |
– • – |
2021-09-21 |
4 |
B |
$9.80 |
$97,966 |
I/I |
10,000 |
35,000 |
2.1 |
% |
|
| ABIO |
Nuvelo Inc |
Chairman of the Board |
– • – |
2021-05-12 |
4 |
B |
$3.19 |
$31,947 |
D/D |
10,000 |
50,000 |
2.39 |
- |
|
| ABIO |
Nuvelo Inc |
Chairman of the Board |
– • – |
2021-05-05 |
4 |
B |
$3.23 |
$32,345 |
D/D |
10,000 |
40,000 |
2.39 |
- |
|
| ABIO |
Nuvelo Inc |
Chairman of the Board |
– • – |
2020-12-18 |
4 |
B |
$4.16 |
$41,630 |
D/D |
10,000 |
30,000 |
2.39 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Director |
– • – |
2020-11-19 |
4 |
B |
$8.03 |
$80,300 |
I/I |
10,000 |
25,000 |
2.1 |
% |
|
| ABIO |
Nuvelo Inc |
Chairman of the Board |
– • – |
2020-09-25 |
4 |
B |
$4.28 |
$21,400 |
D/D |
5,000 |
20,000 |
2.39 |
- |
|
| ABIO |
Nuvelo Inc |
Chairman of the Board |
– • – |
2020-09-22 |
4 |
B |
$4.66 |
$14,241 |
D/D |
3,056 |
15,000 |
2.39 |
- |
|
| ABIO |
Nuvelo Inc |
Chairman of the Board |
– • – |
2020-09-21 |
4 |
B |
$4.77 |
$47,660 |
D/D |
10,000 |
11,944 |
2.39 |
- |
|
| ABIO |
Nuvelo Inc |
Chairman of the Board |
– • – |
2017-07-14 |
4 |
B |
$2.49 |
$24,900 |
D/D |
10,000 |
35,000 |
2.39 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Director |
– • – |
2017-05-09 |
4 |
B |
$2.34 |
$11,700 |
D/D |
5,000 |
45,000 |
2.39 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Director |
– • – |
2017-05-08 |
4 |
B |
$2.28 |
$34,200 |
D/D |
15,000 |
60,000 |
2.39 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Director |
– • – |
2017-05-05 |
4 |
B |
$2.30 |
$46,000 |
D/D |
20,000 |
40,000 |
2.39 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Director |
– • – |
2017-05-04 |
4 |
B |
$2.26 |
$22,600 |
D/D |
10,000 |
20,000 |
2.39 |
- |
|
| ABIO |
Nuvelo Inc |
Director |
– • – |
2017-03-24 |
4 |
B |
$2.59 |
$64,750 |
D/D |
25,000 |
25,000 |
2.39 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Director |
– • – |
2015-12-09 |
4 |
B |
$8.10 |
$81,000 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
